Your browser doesn't support javascript.
loading
miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3/PIK3R1/Akt pathway and induces endothelial cell injury and lipid accumulation.
Li, Hong; Song, Dan; Liu, Qihui; Li, Linlin; Sun, Xiaoshi; Guo, Jiamei; Li, Dianlian; Li, Ping.
Afiliação
  • Li H; Department of Cardiovascular, Shengjing Hospital of China Medical University, Shenyang, China.
  • Song D; School of Pharmacy, China Medical University, Shenyang, China.
  • Liu Q; School of Pharmacy, China Medical University, Shenyang, China.
  • Li L; Shenyang Open University, Shenyang, China.
  • Sun X; Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, China.
  • Guo J; Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, China.
  • Li D; Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, China.
  • Li P; Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, China. s6800@163.com.
Mol Med ; 28(1): 120, 2022 09 30.
Article em En | MEDLINE | ID: mdl-36180828

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Aterosclerose Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Aterosclerose Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Med Ano de publicação: 2022 Tipo de documento: Article